<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38671529</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-7283</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC psychology</Title><ISOAbbreviation>BMC Psychol</ISOAbbreviation></Journal><ArticleTitle>Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations.</ArticleTitle><Pagination><StartPage>236</StartPage><MedlinePgn>236</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">236</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40359-024-01740-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studying individuals with varying symptoms, from mild to severe, can provide valuable insights into the spectrum of cognitive outcomes after COVID-19. We investigated the cognitive performance of adults who recovered from the novel coronavirus disease (COVID-19) without prior cognitive complaints, considering mild (not hospitalized), moderate (ward), and severe (intensive care unit) symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional study included 302 patients who recovered from COVID-19 (mild, n&#x2009;=&#x2009;102; moderate, n&#x2009;=&#x2009;102; severe, n&#x2009;=&#x2009;98). We assessed intellectual quotient (IQ), attention, memory, processing speed, visual-constructive ability, as well as symptoms of depression, anxiety, and stress, at least eighteen months after infection. The mean length of hospitalization was M<sub>days</sub>=8.2 (SD&#x2009;=&#x2009;3.9) and M<sub>days</sub>=14.4 (SD&#x2009;=&#x2009;8.2) in the moderate and severe groups, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Cognitive difficulties were present in all three groups: mild (n&#x2009;=&#x2009;12, 11.7%), moderate (n&#x2009;=&#x2009;40, 39.2%), and severe (n&#x2009;=&#x2009;48, 48.9%). Using Multinomial Logistic Regression and considering the odds ratio, our results indicated that a one-point increase in sustained attention, visual memory, and working memory might decrease the odds of being categorized in the severe group by 20%, 24%, and 77%, respectively, compared to the mild group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings provide empirical evidence regarding the long-term cognitive effects of COVID-19, particularly in individuals experiencing severe manifestations of the disease. We also highlighted the need for a comprehensive, multidimensional approach in rehabilitation programs to address the enduring cognitive impacts of COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de P&#xe1;dua Serafim</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Psychology, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil. serafim@usp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saffi</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Amanda Rafaella A</ForeName><Initials>ARA</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Alessandra Mara</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assed</LastName><ForeName>Mariana Medeiros</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Institute of Psychology, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Toledo</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Psychology, University of Bras&#xed;lia, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Cristiana C A</ForeName><Initials>CCA</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dur&#xe3;es</LastName><ForeName>Ricardo S S</ForeName><Initials>RSS</Initials><AffiliationInfo><Affiliation>Institute of Psychology, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychology, University of Bras&#xed;lia, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020/07957-2</GrantID><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Psychol</MedlineTA><NlmUniqueID>101627676</NlmUniqueID><ISSNLinking>2050-7283</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001288" MajorTopicYN="N">Attention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive difficulties</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuropsychological assessment</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>23</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38671529</ArticleId><ArticleId IdType="pmc">PMC11046800</ArticleId><ArticleId IdType="doi">10.1186/s40359-024-01740-7</ArticleId><ArticleId IdType="pii">10.1186/s40359-024-01740-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;32. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;90. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24(1):176. doi: 10.1186/s13054-020-02882-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02882-x</ArticleId><ArticleId IdType="pmc">PMC7186945</ArticleId><ArticleId IdType="pubmed">32345343</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;62. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty GD, Deary IJ, Luciano M, Altschul DM, Kivim&#xe4;ki M, Gale CR. Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. Brain Behav Immun. 2020;89:569&#x2013;78. doi: 10.1016/j.bbi.2020.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.021</ArticleId><ArticleId IdType="pmc">PMC7297693</ArticleId><ArticleId IdType="pubmed">32561221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcloughlin BC, Miles A, Webb TE, Knopp P, Eyres C, Fabbri A, et al. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020;11(5):857&#x2013;62. doi: 10.1007/s41999-020-00353-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-020-00353-8</ArticleId><ArticleId IdType="pmc">PMC7358317</ArticleId><ArticleId IdType="pubmed">32666303</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinna P, Grewal P, Hall JP, Tavarez T, Dafer RM, Garg R, et al. Neurological manifestations and COVID-19: experiences from a tertiary care center at the Frontline. J Neurol Sci. 2020;415:116969. doi: 10.1016/j.jns.2020.116969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116969</ArticleId><ArticleId IdType="pmc">PMC7832569</ArticleId><ArticleId IdType="pubmed">32570113</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Caruso MJG, Cincoto AV, de Almeida Rocca CC, de P&#xe1;dua Serafim A, Bacchi P, Guedes BF, et al. Post-COVID-19 psychiatric and cognitive morbidity: preliminary findings from a Brazilian cohort study. Gen Hosp Psychiatry. 2022;75:38&#x2013;45. doi: 10.1016/j.genhosppsych.2022.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8734055</ArticleId><ArticleId IdType="pubmed">35134702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. E Clin Med. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS ONE. 2021;16(2):e0246590. doi: 10.1371/journal.pone.0246590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W, Frontera J, Garc&#xed;a-Azor&#xed;n D, Westenberg E, Winkler AS, Mangialasche F, Allegri RF, Kivipelto M. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(5):1047&#x2013;66. doi: 10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, de Sire A, et al. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at Clinical Stability and Clues for Postacute Rehabilitation. Arch Phys Med Rehabil. 2021;102(1):155&#x2013;8. doi: 10.1016/j.apmr.2020.09.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.09.376</ArticleId><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Benito Ballesteros A, Yeung SP, Liu R, Saha A, Curtis L, et al. Cognitive and memory deficits in long COVID: a second publication from the COVID and Cognition Study. Front Aging Neurosci. 2022;14:804937. doi: 10.3389/fnagi.2022.804937.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Calandri I, Corval&#xe1;n N, Carello MA, Keller G, Mart&#xed;nez C, et al. Cognitive consequences of COVID-19: results of a cohort study from South America. Arq Neuropsiquiatr. 2022;80(3):240&#x2013;7. doi: 10.1590/0004-282X-ANP-2021-0320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X-ANP-2021-0320</ArticleId><ArticleId IdType="pmc">PMC9648931</ArticleId><ArticleId IdType="pubmed">34816972</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes ASLM, et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A. 2022;119(35):e2200960119. doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers. Ann Clin Transl Neurol. 2021;8:1073&#x2013;85. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021;27(1):191&#x2013;5. doi: 10.1007/s13365-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2013;4. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Castro PJ, Estivill-Torr&#xfa;s G, Cabezudo-Garc&#xed;a P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia (Engl Ed) 2020;35(4):245&#x2013;51. doi: 10.1016/j.nrl.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7164900</ArticleId><ArticleId IdType="pubmed">32364119</ArticleId></ArticleIdList></Reference><Reference><Citation>He D, Yuan M, Dang W, Bai L, Yang R, Wang J, et al. Long term neuropsychiatric consequences in COVID-19 survivors: cognitive impairment and inflammatory underpinnings 15 months after discharge. Asian J Psychiatr. 2023;80103409. 10.1016/j.ajp.2022.103409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9751007</ArticleId><ArticleId IdType="pubmed">36549172</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452&#x2013;e246816. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E, Malorni W, Long COVID. To investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. 2022;59(2):2102245. doi: 10.1183/13993003.02245-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, Liu F, Zhou T, Israelow B, Wong P, Coppi A, Lucas C, Silva J, Oh JE, Song E, Perotti ES, Zheng NS, Fischer S, Campbell M, Fournier JB, Wyllie AL, Vogels CBF, Ott IM, Kalinich CC, Petrone ME, Watkins AE, Yale IMPACT, Dela Cruz T, Farhadian C, Schulz SF, Ma WL, Grubaugh S, Ko ND, Iwasaki AI, Ring A. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;8. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020; 12(10):9959&#x2013;81. 10.18632/aging.103344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288963</ArticleId><ArticleId IdType="pubmed">32470948</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;75. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerle MB, Sales DS, Pinheiro PG, Gouvea EG, de Almeida PIFM, de Araujo Davico C, et al. Cognitive complaints Assessment and Neuropsychiatric disorders after mild COVID-19 infection. Arch Clin Neuropsychol. 2023;38(2):196&#x2013;204. doi: 10.1093/arclin/acac093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acac093</ArticleId><ArticleId IdType="pubmed">36464245</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90&#x2013;111. doi: 10.1111/nyas.14506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14506</ArticleId><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130&#x2013;40. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, et al. Association between Mood disorders and Risk of COVID-19 infection, hospitalization, and death: a systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(10):1079&#x2013;91. doi: 10.1001/jamapsychiatry.2021.1818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.1818</ArticleId><ArticleId IdType="pmc">PMC8319830</ArticleId><ArticleId IdType="pubmed">34319365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F, Post -COVID-19 depressive symptoms: Epidemiology, Pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S, Palladini M, Mazza MG, De Lorenzo R, COVID-19 BioB Outpatient Clinic Study group Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci. 2022;272(5):773&#x2013;82. doi: 10.1007/s00406-021-01346-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01346-9</ArticleId><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. Escala Wechsler Abreviada de Intelig&#xea;ncia (WASI). S&#xe3;o Paulo. Casa do Psic&#xf3;logo. 2014.</Citation></Reference><Reference><Citation>Wechsler D. Escala de Intelig&#xea;ncia Wechsler para Adultos WAIS III &#x2013; Revis&#xe3;o das Normas Brasileiras da Escala de Intelig&#xea;ncia Wechsler para Adultos. S&#xe3;o Paulo. Casa do Psic&#xf3;logo. 2020.</Citation></Reference><Reference><Citation>Lance ACN, Esteves C, Arsuffi ES, Lima FF, Reis JS. Teste De Aten&#xe7;&#xe3;o Concentrada. S&#xe3;o Paulo. Editora Vetor; 2020.</Citation></Reference><Reference><Citation>Rey A. Figuras complexas de Rey. S&#xe3;o Paulo. Casa do Psic&#xf3;logo. 2014.</Citation></Reference><Reference><Citation>Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014;155:104&#x2013;9. doi: 10.1016/j.jad.2013.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2013.10.031</ArticleId><ArticleId IdType="pubmed">24238871</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkweather J, Moske A, Multinomial Logistic R. 2011. Available online: https://it.unt.edu/sites/default/files/mlr_jds_aug2011.pdf (accessed on 8 September 2023).</Citation></Reference><Reference><Citation>F&#xe1;vero LPL, Belfiore PP, da Silva FL, Chan BL. An&#xe1;lise de dados: modelagem multivariada para tomada de decis&#xf5;es. Elsevier; 2009.</Citation></Reference><Reference><Citation>Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry. 2010;19(3):227&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938757</ArticleId><ArticleId IdType="pubmed">20842279</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the behavioral sciences. New York, NY: Routledge Academic; 1988.</Citation></Reference><Reference><Citation>Tenny S, Hoffman MR. Odds ratio. StatPearls. Treasure Island (FL). Volume 22. StatPearls Publishing; 2023.</Citation></Reference><Reference><Citation>Khraisat B, Toubasi A, AlZoubi L, Al-Sayegh T, Mansour A. Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Int J Psychiatry Clin Pract. 2022;26(3):234&#x2013;43. doi: 10.1080/13651501.2021.1993924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2021.1993924</ArticleId><ArticleId IdType="pubmed">34709105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. E Clin Med. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes EA, O&#x2019;Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547&#x2013;60. doi: 10.1016/S2215-0366(20)30168-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30168-1</ArticleId><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F, Aggio V, Pratesi ML, Greco G, Furlan R. Neuroinflammation in Bipolar Depression. Front Psychiatry. 2020;11:71. doi: 10.3389/fpsyt.2020.00071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.00071</ArticleId><ArticleId IdType="pmc">PMC7054443</ArticleId><ArticleId IdType="pubmed">32174850</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C, Hu S. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarty T, Hadjipavlou G, Lam RW. Cognitive dysfunction in major depressive disorder: Assessment, Impact, and management. Focus (Am Psychiatr Publ) 2016;14(2):194&#x2013;206. doi: 10.1176/appi.focus.20150043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.focus.20150043</ArticleId><ArticleId IdType="pmc">PMC6519654</ArticleId><ArticleId IdType="pubmed">31975803</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique LA, Jakabek D, Bracken SG et al. Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study. 2022. Preprint at medRxiv 10.1101/2022.06.07.22276020.</Citation></Reference><Reference><Citation>Woo MS, Malsy J, P&#xf6;ttgen J, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2(2):fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan B, Li W, Liu H, Cai X, Song S, Zhao J, et al. Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav Immun. 2020;88:39&#x2013;43. doi: 10.1016/j.bbi.2020.05.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.062</ArticleId><ArticleId IdType="pmc">PMC7247486</ArticleId><ArticleId IdType="pubmed">32464158</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667&#x2013;73. doi: 10.1016/j.jiph.2020.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.03.019</ArticleId><ArticleId IdType="pmc">PMC7142680</ArticleId><ArticleId IdType="pubmed">32340833</ArticleId></ArticleIdList></Reference><Reference><Citation>Emami Zeydi A, Ghazanfari MJ, Sanandaj FS, et al. Coronavirus Disease 2019 (COVID-19): a Literature Review from a nursing perspective. Biomed (Taipei) 2021;11(3):5&#x2013;14. doi: 10.37796/2211-8039.1154.</Citation><ArticleIdList><ArticleId IdType="doi">10.37796/2211-8039.1154</ArticleId><ArticleId IdType="pmc">PMC8823490</ArticleId><ArticleId IdType="pubmed">35223405</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>